Floatz logo

132 assets in Cognitive Disorder

Therapeutic assets addressing Cognitive Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Silymarin
Cognitive Disorder
Tanta UniversityP2/3CCC (55)
Trans-Resveratrol
Cognitive Disorder
Zaparackas and Knepper LTDP2CCC (55)
Bacillus Calmette-Guerin Live Antigen, Unspecified Substrain
Cognitive Disorder
Steven E Arnold, MDP2CCC (54)
Dasatinib
Cognitive Disorder
Mayo ClinicP2CCC (54)
Empagliflozin
Cognitive Disorder
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolP2CCC (54)
Alto-101
Cognitive Disorder
Alto NeuroscienceP2CCC (53)
Benzoic Acid
Cognitive Disorder
National Cheng-Kung University HospitalP2CCC (53)
ci-581a
Cognitive Disorder
New York State Psychiatric InstituteP2CCC (53)
ci-581b
Cognitive Disorder
New York State Psychiatric InstituteP2CCC (53)
Cromoglicic Acid
Cognitive Disorder
AZTherapies, Inc.P2CCC (53)
Edaravone Dexborneol Sublingual
Cognitive Disorder
Simcere Pharmaceutical Co., LtdP2CCC (53)
Formoterol
Cognitive Disorder
Palo Alto Veterans Institute for ResearchP2CCC (53)
Ibogaine
Cognitive Disorder
Johns Hopkins UniversityP2CCC (53)
Modafinil Generis
Cognitive Disorder
Clinical Academic Center (2CA-Braga)P2CCC (53)
N-(5-ISOQUINOLINESULFONYL)-1,4-PERHYDRODIAZEPINE
Cognitive Disorder
Helse Stavanger HFP2CCC (53)
S-Equol
Cognitive Disorder
Akira SekikawaP2CCC (53)
Tian Ma Bian Chun Zhi Gan Tablets
Cognitive Disorder
Dongzhimen Hospital, BeijingP2CCC (53)
Caffeine Mixture With Citric Acid
Cognitive Disorder
University of MichiganP2CCC (51)
Cort108297
Cognitive Disorder
Johns Hopkins UniversityP2CCC (51)
Cot
Cognitive Disorder
Evon Medics LLCP2CCC (51)
Dextrose Solution
Cognitive Disorder
University of MichiganP2CCC (51)
Human Mesenchymal Stem Cells
Cognitive Disorder
Bernard (Barry) BaumelP2CCC (51)
Lamivudine
Cognitive Disorder
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la CienciaP2CCC (51)
Mitoquinone Mesilate
Cognitive Disorder
UConn HealthP2CCC (51)
Nevadistinel
Cognitive Disorder
AptinyxP2CCC (51)
Nicorandil
Cognitive Disorder
Gregory Jicha, MD, PhDP2CCC (51)
Ntrx-07
Cognitive Disorder
NeuroTherapia, Inc.P2CCC (51)
Progesterone Soft
Cognitive Disorder
Beijing Tiantan HospitalP2CCC (51)
Roflumilast
Cognitive Disorder
Maastricht University Medical CenterP2CCC (51)
Semaglutide
Cognitive Disorder
Rutgers, The State University of New JerseyP2CCC (51)
Senicapoc
Cognitive Disorder
University of California, DavisP2CCC (51)
Sirolimus
Cognitive Disorder
The University of Texas Health Science Center at San AntonioP2CCC (51)
Tacrolimus
Cognitive Disorder
Massachusetts General HospitalP2CCC (51)
Tebonin Forte
Cognitive Disorder
National Neuroscience InstituteP2CCC (51)
Immunoglobulin G1, Anti-(Human Interleukin 1.Beta.) (Human Clone Acz885 Heavy Chain V Region)
Cognitive Disorder
Novartis PharmaceuticalsP2CCC (50)
Lidocaine
Cognitive Disorder
University of Dublin, Trinity CollegeP1/2CCC (50)
Admsc
Cognitive Disorder
Paul E SchulzP1/2CCC (48)
Pegipanermin
Cognitive Disorder
Inmune Bio, Inc.P2CCC (48)
Azd-0328
Cognitive Disorder
King's College LondonP2CC (46)
Baricitinib
Cognitive Disorder
Massachusetts General HospitalP1/2CC (46)
Centella Asiatica Water Extract Product
Cognitive Disorder
Oregon Health and Science UniversityP1CC (46)
Cyclophosphamide
Cognitive Disorder
University of WashingtonP1/2CC (46)
Kyn-5356
Cognitive Disorder
Kynexis B.V.P1CC (46)
Prilocaine
Cognitive Disorder
University of Dublin, Trinity CollegeP1/2CC (46)
Pentoxifylline
Cognitive Disorder
The First Hospital of Hebei Medical UniversityP1/2CC (45)
[18F]MC225
Cognitive Disorder
University Medical Center GroningenP1/2CC (43)
Brivaracetam
Cognitive Disorder
University of California, Los AngelesP1/2CC (43)
Salicylamine Acetate
Cognitive Disorder
MTI Biotech IncP1/2CC (43)
Blood Plasma
Cognitive Disorder
Mayo ClinicP1CC (42)
Phenserine
Cognitive Disorder
Helse Stavanger HFP1CC (42)
Showing 51 to 100 of 132 assets
PreviousPage 2 of 3Next